Myelographic complications associated with drug interactions.

被引：3

作者：

Fluke, M ^{[1
]}

机构：

[1] Irvington Radiologists PC, Community Hosp Indianapolis, Indianapolis, IN 46256 USA

来源：

关键词：

D O I：

10.2214/ajr.177.3.1770713

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：713 / 713

页数：1

共 50 条

[1] Drug interactions.
Ernst, E
PERFUSION, 2000, 13 (01): : 1 - 1
[2] Drug-drug interactions.: An update
Morales-Olivas, Francisco J.
Estan, Luis
MEDICINA CLINICA, 2006, 127 (07): : 269 - 275
[3] Drug-drug interactions. Interactions between xenobiotics
Haen, E.
NERVENARZT, 2014, 85 (04): : 417 - +
[4] The main pharmacokinetic drug interactions.
Buxeraud, Jacques
Faure, Sebastien
Picard, Nicolas
ACTUALITES PHARMACEUTIQUES, 2016, 55 (554): : 6 - 15
[5] The main pharmacodynamic drug interactions.
Buxeraud, Jacques
Faure, Sebastien
Picard, Nicolas
ACTUALITES PHARMACEUTIQUES, 2016, 55 (554): : 17 - 21
[6] Principle of System Balance for Drug Interactions.
Xavier, Joao B.
Sander, Chris
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14): : 1339 - 1340
[7] Plasma protein binding of amprenavir and drug-drug interactions.
Taburet, A
Barrail, A
Le Tiec, C
Vincent, I
Chène, G
Raguin, G
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P15 - P15
[8] Identification of drug targets via their intracellular interactions.
Ohana, Rachel Friedman
Robers, Matt
Kirkland, Thomas A.
Woodroofe, Carolyn C.
Zimprich, Chad
Uyeda, Tetsuo H.
Otto, Paul
Levin, Sergiy
Wood, Keith
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[9] Drug Interactions. Practical Implementation in interdisciplinary Cooperation
Aretin, M. -B.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 71 - 71
[10] Pioglitazone has low potential for drug interactions.
Kortboyer, JM
Eckland, DJA
DIABETOLOGIA, 1999, 42 : A228 - A228